Published in
Taylor & Francis, Expert Opinion on Drug Safety, 9(20), p. 1125-1136, 2021
DOI: 10.1080/14740338.2021.1946513
Links
Tools
Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
Journal article published in 2021 by
Jaykaran Charan 
,
Siddhartha Dutta ,
Rimplejeet Kaur,
Pankaj Bhardwaj,
Praveen Sharma ,
Sneha Ambwani,
Iffat Jahan ,
Abdullahi Rabiu Abubakar,
Salequl Islam ,
Timothy Craig Hardcastle ,
Nor Azlina A. Rahman ,
Halyna Lugova ,
Mainul Haque
,
Siddhartha Dutta ,
Rimplejeet Kaur,
Pankaj Bhardwaj,
Praveen Sharma ,
Sneha Ambwani,
Iffat Jahan ,
Abdullahi Rabiu Abubakar,
Salequl Islam ,
Timothy Craig Hardcastle ,
Nor Azlina A. Rahman ,
Halyna Lugova ,
Mainul Haque
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 